| Insideraktier | 26 630 802 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Radius Recycling, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i RDUS / Radius Recycling, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i RDUS / Radius Recycling, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-30 | 2022-08-11 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 10,0000 | −8 733 538 | −87 335 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Common Stock | D | 10,0000 | −5 500 | −55 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Murphy Sean | RDUS | Common Stock | D | 10,0000 | −5 500 | −55 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 10,0000 | −5 500 | −55 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 10,0000 | −26 800 | −268 | 5 500 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Martin G. Kelly | RDUS | Common Stock | D | 10,0000 | −75 000 | −750 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Holtschlag Danielle | RDUS | Common Stock | D | 10,0000 | −25 000 | −250 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Messersmith Elizabeth | RDUS | Common Stock | D | 10,0000 | −70 000 | −700 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Hughes Owen | RDUS | Common Stock | D | 10,0000 | −21 650 | −216 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Dere Willard H | RDUS | Common Stock | D | 10,0000 | −1 895 | −19 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Dere Willard H | RDUS | Common Stock | D | 10,0000 | −21 300 | −213 | 1 895 | ||||
| 2022-08-15 | 2022-08-15 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 10,0000 | −26 800 | −268 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Shah Chhaya | RDUS | Common Stock | D | 10,0000 | −94 645 | −946 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | SANDERS MACHELLE | RDUS | Common Stock | D | 10,0000 | −5 500 | −55 | 0 | ||||
| 2022-08-12 | 2022-08-11 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 10,0700 | 1 678 954 | 16 907 | 8 642 271 | ||||
| 2022-08-11 | 2022-08-10 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 10,0700 | 4 012 | 40 | 6 963 317 | ||||
| 2022-05-20 | 2022-05-18 | 4 | Lisa Susan Vissers | RDUS | Stock Option (Right to Buy) | D | 5,84 | 30 000 | 30 000 | |||||
| 2022-05-20 | 2022-05-18 | 4 | Jarrett Jennifer | RDUS | Stock Option (Right to Buy) | D | 5,84 | 30 000 | 30 000 | |||||
| 2022-05-20 | 2022-05-18 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 5,5690 | 477 824 | 2 661 | 8 733 538 | ||||
| 2022-03-17 | 2022-03-15 | 4 | Conley Mark William | RDUS | Common Stock | D | 50 000 | 50 000 | ||||||
| 2022-02-28 | 3 | Messersmith Elizabeth | RDUS | Common Stock | D | 70 000 | ||||||||
| 2022-02-25 | 2022-02-21 | 4 | Martin G. Kelly | RDUS | Common Stock | D | 75 000 | 75 000 | ||||||
| 2022-02-23 | 2022-02-21 | 4 | Martin G. Kelly | RDUS | Common Stock | D | 960 000 | 960 000 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Helwig Steven | RDUS | Common Stock | D | 15 000 | 31 251 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | SANDERS MACHELLE | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10 000 | 10 000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | SANDERS MACHELLE | RDUS | Common Stock | D | 5 500 | 5 500 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10 000 | 10 000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | Hughes Owen | RDUS | Common Stock | D | 5 500 | 21 650 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10 000 | 10 000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Common Stock | D | 5 500 | 5 500 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Shah Chhaya | RDUS | Common Stock | D | 65 000 | 94 645 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10 000 | 10 000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5 500 | 26 800 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10 000 | 10 000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | Dere Willard H | RDUS | Common Stock | D | 5 500 | 23 195 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10 000 | 10 000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5 500 | 26 800 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Holtschlag Danielle | RDUS | Common Stock | D | 25 000 | 25 000 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10 000 | 10 000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | Murphy Sean | RDUS | Common Stock | D | 5 500 | 11 000 | ||||||
| 2022-01-07 | 2022-01-06 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 6,3147 | 300 000 | 1 894 | 8 255 714 | ||||
| 2022-01-07 | 2022-01-05 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 6,2986 | 250 000 | 1 575 | 7 955 714 | ||||
| 2021-12-16 | 2021-12-16 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 7,0747 | 146 685 | 1 038 | 6 959 305 | ||||
| 2021-12-15 | 2021-12-15 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 6,7700 | 180 744 | 1 224 | 6 812 620 | ||||
| 2021-12-15 | 2021-12-14 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 6,8110 | 94 103 | 641 | 6 631 876 | ||||
| 2021-12-15 | 2021-12-13 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 7,0804 | 187 391 | 1 327 | 6 537 773 | ||||
| 2021-12-10 | 2021-12-10 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 7,1750 | 768 171 | 5 512 | 6 350 382 | ||||
| 2021-12-10 | 2021-12-09 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 7,5841 | 264 644 | 2 007 | 5 582 211 | ||||
| 2021-12-10 | 2021-12-08 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 8,0206 | 560 691 | 4 497 | 5 317 567 | ||||
| 2021-12-10 | 3 | Rubric Capital Management LP | RDUS | Common stock, par value $0.0001 per share | I | 4 756 876 | ||||||||
| 2021-10-18 | 2021-10-15 | 4 | Holtschlag Danielle | RDUS | Stock Option (Right to Buy) | D | 15,10 | 50 000 | 50 000 | |||||
| 2021-10-01 | 2021-09-29 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 12,9450 | 100 000 | 1 294 | 7 705 714 | ||||
| 2021-09-24 | 2021-09-22 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 12,2752 | 150 000 | 1 841 | 7 605 714 | ||||
| 2021-09-23 | 2021-05-17 | 4 | Shah Chhaya | RDUS | Common Stock | D | 10 000 | 29 645 | ||||||
| 2021-08-26 | 2021-08-24 | 4 | Helwig Steven | RDUS | Common | D | 5 125 | 20 829 | ||||||
| 2021-08-26 | 3 | Helwig Steven | RDUS | Common Stock | D | 15 704 | ||||||||
| 2021-03-24 | 3 | Shah Chhaya | RDUS | Common Stock | D | 19 645 | ||||||||
| 2021-03-24 | 2021-02-22 | 4/A | Martin G. Kelly | RDUS | Stock Option (Right to Buy) | D | 28,60 | 460 000 | 460 000 | |||||
| 2021-03-09 | 2021-03-05 | 4 | Chopas James George | RDUS | Common Stock | D | 20,8800 | −370 | −8 | 6 701 | ||||
| 2021-02-26 | 2021-02-25 | 4 | Grausso Sal | RDUS | Common Stock | D | 18,9300 | −1 322 | −25 | 11 709 | ||||
| 2021-02-23 | 2021-02-22 | 4 | Chopas James George | RDUS | Stock Option (Right to Buy) | D | 18,60 | 20 000 | 20 000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Grausso Sal | RDUS | Stock Option (Right to Buy) | D | 18,60 | 60 000 | 60 000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10 000 | 10 000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Murphy Sean | RDUS | Common Stock | D | 5 500 | 5 500 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10 000 | 10 000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Dere Willard H | RDUS | Common Stock | D | 5 500 | 17 695 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10 000 | 10 000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5 500 | 21 300 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10 000 | 10 000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5 500 | 21 300 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | Martin G. Kelly | RDUS | Stock Option (Right to Buy) | D | 28,60 | 460 000 | 460 000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10 000 | 10 000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Hughes Owen | RDUS | Common Stock | D | 5 500 | 16 150 | ||||||
| 2021-01-25 | 2021-01-21 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 22,00 | 20 000 | 20 000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 22,00 | 20 000 | 20 000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 22,00 | 20 000 | 20 000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 22,00 | 20 000 | 20 000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 22,00 | 40 000 | 40 000 | |||||
| 2021-01-21 | 2021-01-20 | 4 | Chopas James George | RDUS | Stock Option (Right to Buy) | D | 21,66 | 20 000 | 20 000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Stock Option (Right to Buy) | D | 18,17 | 30 000 | 30 000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | SANDERS MACHELLE | RDUS | Stock Option (Right to Buy) | D | 18,17 | 30 000 | 30 000 | |||||
| 2020-12-18 | 3 | Chopas James George | RDUS | Common Stock | D | 1 492 | ||||||||
| 2020-11-10 | 2020-11-09 | 4 | Dolan Dan | RDUS | Stock Option (Right to Buy) | D | 14,08 | 12 000 | 12 000 | |||||
| 2020-11-10 | 2020-11-09 | 4 | Grausso Sal | RDUS | Stock Option (Right to Buy) | D | 14,08 | 15 000 | 15 000 | |||||
| 2020-11-10 | 3 | Grausso Sal | RDUS | Common Stock | D | 531 | ||||||||
| 2020-11-09 | 2020-11-05 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 14,2623 | 100 000 | 1 426 | 7 455 714 | ||||
| 2020-09-16 | 2020-09-14 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 11,6934 | 200 000 | 2 339 | 7 355 714 | ||||
| 2020-09-14 | 2020-09-11 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 11,3306 | 199 029 | 2 255 | 7 155 714 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 12,61 | 30 000 | 30 000 | |||||
| 2020-07-09 | 2020-07-08 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 13,2071 | 25 000 | 330 | 6 956 685 | ||||
| 2020-05-04 | 2020-04-30 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 15,7511 | 50 000 | 788 | 6 931 685 | ||||
| 2020-04-29 | 2020-04-28 | 4 | Martin G. Kelly | RDUS | Stock Option (Right to Buy) | D | 16,46 | 575 000 | 575 000 | |||||
| 2020-02-28 | 2020-02-26 | 4 | Carmona Jose | RDUS | Common Stock | D | 17,9330 | −1 292 | −23 | 46 708 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Dere Willard H | RDUS | Common Stock | D | 17,9500 | −1 925 | −35 | 12 195 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 17,9500 | −1 815 | −33 | 12 401 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Morris Charles Q | RDUS | Common Stock | D | 17,9330 | −1 256 | −23 | 33 744 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Hughes Owen | RDUS | Common Stock | D | 17,9500 | −2 750 | −49 | 10 650 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 17,9330 | −889 | −16 | 24 111 | ||||
| 2020-02-24 | 2020-02-20 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10 000 | 10 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5 500 | 15 800 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10 000 | 10 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Graves Kurt | RDUS | Common Stock | D | 5 500 | 11 000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 19,96 | 107 000 | 107 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Hopfield Jessica | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10 000 | 10 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Hopfield Jessica | RDUS | Common Stock | D | 5 500 | 18 300 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10 000 | 10 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Hughes Owen | RDUS | Common Stock | D | 5 500 | 13 400 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 19,96 | 25 000 | 25 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 17 500 | 25 000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Morris Charles Q | RDUS | Stock Option (Right to Buy) | D | 19,96 | 30 000 | 30 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Morris Charles Q | RDUS | Common Stock | D | 20 000 | 35 000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10 000 | 10 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 5 500 | 14 216 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 19,96 | 45 000 | 45 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Carmona Jose | RDUS | Common Stock | D | 30 000 | 48 000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Dere Willard H | RDUS | Common Stock (Right to Buy) | D | 19,96 | 10 000 | 10 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Dere Willard H | RDUS | Common Stock | D | 5 500 | 14 120 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10 000 | 10 000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5 500 | 15 800 | ||||||
| 2019-11-08 | 2019-11-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 23,0030 | 100 000 | 2 300 | 6 881 685 | ||||
| 2019-07-03 | 2019-07-01 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 24,6000 | −1 584 | −39 | 8 716 | ||||
| 2019-06-11 | 2019-06-07 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 21,8144 | 2 500 | 55 | 7 500 | ||||
| 2019-05-13 | 2019-05-10 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 21,4300 | 2 000 | 43 | 5 000 | ||||
| 2019-04-18 | 2019-04-16 | 4 | Dere Willard H | RDUS | Common Stock | D | 22,2200 | −1 680 | −37 | 8 620 | ||||
| 2019-04-18 | 2019-04-16 | 4 | Graves Kurt | RDUS | Common Stock | D | 22,3200 | −4 800 | −107 | 5 500 | ||||
| 2019-04-18 | 2019-04-16 | 4 | Hughes Owen | RDUS | Common Stock | D | 22,2200 | −2 400 | −53 | 7 900 | ||||
| 2019-04-12 | 2019-04-11 | 4 | Roychowdhury Debasish | RDUS | Common Stock | D | 22,1500 | −4 800 | −106 | 5 500 | ||||
| 2019-03-06 | 2019-03-05 | 4 | Hopfield Jessica | RDUS | Common Stock | D | 19,2336 | 12 800 | 246 | 12 800 | ||||
| 2019-02-26 | 2019-02-22 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 19,18 | 55 000 | 55 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Carmona Jose | RDUS | Common Stock | D | 15 000 | 18 000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10 000 | 10 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Roychowdhury Debasish | RDUS | Common Stock | D | 5 500 | 10 300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10 000 | 10 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 5 500 | 10 300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Morris Charles Q | RDUS | Stock Option (Right to Buy) | D | 19,18 | 55 000 | 55 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Morris Charles Q | RDUS | Common Stock | D | 15 000 | 15 000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 19,18 | 30 000 | 30 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 10 000 | 13 000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10 000 | 10 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Hughes Owen | RDUS | Common Stock | D | 5 500 | 10 300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Hoiland Jesper | RDUS | Performance Stock Units | D | 71 000 | 71 000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 19,18 | 128 000 | 128 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 19,18 | 55 000 | 55 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Hatzis-Schoch Brent | RDUS | Common Stock | D | 15 000 | 17 944 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Options (Right to Buy) | D | 19,18 | 10 000 | 10 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5 500 | 10 300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10 000 | 10 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5 500 | 10 300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10 000 | 10 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Graves Kurt | RDUS | Common Stock | D | 5 500 | 10 300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Dere Willard H | RDUS | Common Stock (Right to Buy) | D | 19,18 | 10 000 | 10 000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Dere Willard H | RDUS | Common Stock | D | 5 500 | 10 300 | ||||||
| 2019-02-19 | 2019-02-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock Warrant (right to buy) | D | 14,00 | −71 409 | 0 | |||||
| 2019-02-19 | 2019-02-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 14,0040 | 71 409 | 1 000 | 6 781 685 | ||||
| 2019-02-13 | 2019-02-13 | 4 | Dere Willard H | RDUS | Restricted Stock Units | D | −4 800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Dere Willard H | RDUS | Common Stock | D | 4 800 | 4 800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | FRIEDMAN CATHY | RDUS | Restricted Stock Units | D | −4 800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 4 800 | 4 800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Restricted Stock Units | D | −4 800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 4 800 | 4 800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Graves Kurt | RDUS | Restricted Stock Units | D | −4 800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Graves Kurt | RDUS | Common Stock | D | 4 800 | 4 800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Hughes Owen | RDUS | Restricted Stock Units | D | −4 800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Hughes Owen | RDUS | Common Stock | D | 4 800 | 4 800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Rosenberg Anthony | RDUS | Restricted Stock Units | D | −4 800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 4 800 | 4 800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Roychowdhury Debasish | RDUS | Restricted Stock Units | D | −4 800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Roychowdhury Debasish | RDUS | Common Stock | D | 4 800 | 4 800 | ||||||
| 2019-01-25 | 2019-01-24 | 4 | Hopfield Jessica | RDUS | Stock Option (Right to Buy) | D | 17,10 | 30 000 | 30 000 | |||||
| 2018-12-21 | 2018-12-20 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 14,4797 | 60 000 | 869 | 6 710 276 | ||||
| 2018-12-18 | 2018-12-17 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 15,7100 | 3 000 | 47 | 3 000 | ||||
| 2018-12-17 | 2018-12-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 15,6376 | 60 000 | 938 | 6 650 276 | ||||
| 2018-09-05 | 2018-09-04 | 4 | Morris Charles Q | RDUS | Stock Option (Right to Buy) | D | 19,93 | 130 000 | 130 000 | |||||
| 2018-08-22 | 2018-08-20 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 19,6468 | 60 000 | 1 179 | 6 590 276 | ||||
| 2018-08-16 | 2018-08-15 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 20,7824 | 69 363 | 1 442 | 6 530 276 | ||||
| 2018-08-16 | 2018-08-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 20,8688 | 100 000 | 2 087 | 6 460 913 | ||||
| 2018-08-10 | 2018-08-08 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 22,7314 | 60 000 | 1 364 | 6 360 913 | ||||
| 2018-07-30 | 2018-07-27 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 24,8121 | 50 000 | 1 241 | 6 300 913 | ||||
| 2018-07-26 | 2018-07-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 27,2761 | 50 000 | 1 364 | 6 250 913 | ||||
| 2018-06-13 | 2018-06-11 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 27,3567 | 50 000 | 1 368 | 6 200 913 | ||||
| 2018-05-24 | 2018-05-23 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 28,9080 | 40 000 | 1 156 | 6 150 913 | ||||
| 2018-05-23 | 2018-05-21 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 29,2730 | 60 000 | 1 756 | 6 110 913 | ||||
| 2018-04-23 | 2018-04-19 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,7984 | 40 000 | 1 352 | 6 050 913 | ||||
| 2018-04-16 | 2018-04-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock Warrant (right to buy) | D | 14,00 | −107 114 | 71 409 | |||||
| 2018-04-16 | 2018-04-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 14,0040 | 107 114 | 1 500 | 6 010 913 | ||||
| 2018-04-09 | 2018-04-05 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,5769 | 50 000 | 1 829 | 5 903 799 | ||||
| 2018-03-06 | 2018-03-02 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32,5181 | 80 000 | 2 601 | 5 853 799 | ||||
| 2018-02-15 | 2018-02-13 | 4 | Roychowdhury Debasish | RDUS | Restricted Stock Units | D | 4 800 | 4 800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8 800 | 8 800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 37,83 | 60 000 | 60 000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Dere Willard H | RDUS | Restricted Stock Units | D | 4 800 | 4 800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8 800 | 8 800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | FRIEDMAN CATHY | RDUS | Restricted Stock Units | D | 4 800 | 4 800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8 800 | 8 800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Restricted Stock Units | D | 4 800 | 4 800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8 800 | 8 800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Graves Kurt | RDUS | Restricted Stock Units | D | 4 800 | 4 800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8 800 | 8 800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 37,83 | 60 000 | 60 000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 37,83 | 60 000 | 60 000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 37,83 | 210 000 | 210 000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hughes Owen | RDUS | Restricted Stock Units | D | 4 800 | 4 800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8 800 | 8 800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 37,83 | 30 000 | 30 000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Rosenberg Anthony | RDUS | Restricted Stock Units | D | 4 800 | 4 800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8 800 | 8 800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 37,83 | 60 000 | 60 000 | |||||
| 2018-02-12 | 2018-02-09 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34,3835 | 75 000 | 2 579 | 5 773 799 | ||||
| 2017-11-28 | 2017-11-27 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 27,80 | 60 000 | 60 000 | |||||
| 2017-11-16 | 2017-11-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 26,2478 | 50 000 | 1 312 | 5 698 799 | ||||
| 2017-11-13 | 2017-11-10 | 4 | Hatzis-Schoch Brent | RDUS | Common Stock | D | 28,0893 | 1 778 | 50 | 2 278 | ||||
| 2017-11-07 | 2017-11-07 | 4 | Hoiland Jesper | RDUS | Common Stock | D | 29,0368 | 6 800 | 197 | 12 900 | ||||
| 2017-11-07 | 2017-11-03 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 29,1515 | 50 000 | 1 458 | 5 648 799 | ||||
| 2017-10-27 | 2017-10-26 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 30,9510 | 50 000 | 1 548 | 5 598 799 | ||||
| 2017-10-26 | 2017-10-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32,8483 | 50 000 | 1 642 | 5 548 799 | ||||
| 2017-09-15 | 2017-09-15 | 4 | Hoiland Jesper | RDUS | Common Stock | D | 32,7227 | 6 100 | 200 | 6 100 | ||||
| 2017-09-15 | 2017-09-14 | 4 | Carmona Jose | RDUS | Common Stock | D | 32,8343 | 3 000 | 99 | 3 000 | ||||
| 2017-09-15 | 2017-09-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32,9445 | 50 000 | 1 647 | 5 498 799 | ||||
| 2017-09-15 | 2017-09-13 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,7075 | 100 000 | 3 371 | 5 448 799 | ||||
| 2017-09-13 | 2017-09-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,4164 | 50 000 | 1 771 | 5 348 799 | ||||
| 2017-09-07 | 2017-09-05 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,7525 | 50 000 | 1 838 | 5 298 799 | ||||
| 2017-08-18 | 2017-08-16 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,9756 | 60 000 | 2 159 | 5 248 799 | ||||
| 2017-08-11 | 2017-08-10 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34,2600 | 75 000 | 2 570 | 5 188 799 | ||||
| 2017-08-11 | 2017-08-09 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,6737 | 75 000 | 2 676 | 5 113 799 | ||||
| 2017-07-18 | 3 | Hoiland Jesper | RDUS | No securities are beneficially owned. | D | 0 | ||||||||
| 2017-07-18 | 2017-07-17 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 42,97 | 305 000 | 305 000 | |||||
| 2017-05-31 | 2017-05-30 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34,2087 | 40 000 | 1 368 | 5 038 799 | ||||
| 2017-05-30 | 2017-05-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,2505 | 40 000 | 1 450 | 4 998 799 | ||||
| 2017-05-22 | 2017-05-18 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34,4069 | 50 000 | 1 720 | 4 958 799 | ||||
| 2017-05-18 | 2017-05-17 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32,9812 | 18 000 | 594 | 4 908 799 | ||||
| 2017-05-18 | 2017-05-16 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,9250 | 17 000 | 577 | 4 890 799 | ||||
| 2017-05-16 | 2017-05-15 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 34,96 | 125 000 | 125 000 | |||||
| 2017-05-16 | 2017-05-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,9997 | 15 000 | 510 | 4 873 799 | ||||
| 2017-05-11 | 2017-05-09 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,9296 | 50 000 | 1 796 | 4 858 799 | ||||
| 2017-05-09 | 2017-05-08 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,5978 | 22 800 | 812 | 4 808 799 | ||||
| 2017-05-09 | 2017-05-05 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,5477 | 20 600 | 732 | 4 785 999 | ||||
| 2017-05-03 | 2017-05-02 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,9056 | 75 000 | 2 543 | 4 765 399 | ||||
| 2017-05-02 | 2017-05-01 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,3907 | 150 000 | 5 309 | 4 690 399 | ||||
| 2017-04-27 | 2017-04-25 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to buy) | D | 2,74 | −11 838 | 0 | |||||
| 2017-04-27 | 2017-04-25 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to buy) | D | 2,74 | −27 778 | 0 | |||||
| 2017-04-27 | 2017-04-25 | 4 | Harvey Brian Nicholas | RDUS | Common Stock | D | 2,7400 | 39 616 | 109 | 76 189 | ||||
| 2017-03-22 | 2017-03-21 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,8325 | 50 000 | 1 792 | 4 540 399 | ||||
| 2017-03-22 | 2017-03-20 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 2,05 | −23 416 | 0 | |||||
| 2017-03-22 | 2017-03-20 | 4 | Harvey Brian Nicholas | RDUS | Common Stock | D | 2,0500 | 23 416 | 48 | 36 573 | ||||
| 2017-03-21 | 2017-03-17 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 38,4083 | 30 000 | 1 152 | 4 490 399 | ||||
| 2017-03-16 | 2017-03-15 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39,9560 | 44 469 | 1 777 | 4 460 399 | ||||
| 2017-03-16 | 2017-03-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39,9993 | 17 252 | 690 | 4 415 930 | ||||
| 2017-03-14 | 2017-03-10 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39,1673 | 38 279 | 1 499 | 4 398 678 | ||||
| 2017-02-22 | 2017-02-17 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27 500 | 27 500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27 500 | 27 500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Snow David P. | RDUS | Stock Option (Right to Buy) | D | 45,65 | 75 000 | 75 000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 45,65 | 187 800 | 187 800 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 45,65 | 75 000 | 75 000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27 500 | 27 500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Fitzpatrick Lorraine A. | RDUS | Stock Option (Right to Buy) | D | 45,65 | 45 000 | 45 000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27 500 | 27 500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27 500 | 27 500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27 500 | 27 500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27 500 | 27 500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 45,65 | 55 000 | 55 000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 45,65 | 75 000 | 75 000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 45,65 | 60 000 | 60 000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27 500 | 27 500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Purandare Dinesh | RDUS | Stock Option (Right to Buy) | D | 45,65 | 35 000 | 35 000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27 500 | 27 500 | |||||
| 2016-10-25 | 2016-10-25 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 7,80 | −10 000 | 733 785 | |||||
| 2016-10-25 | 2016-10-25 | 4 | Ward Robert | RDUS | Common Stock | D | 7,8000 | 10 000 | 78 | 15 000 | ||||
| 2016-09-29 | 2016-09-27 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | −1 229 902 | 2 459 804 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | −1 229 902 | 2 459 804 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | GADICKE ANSBERT | RDUS | Common Stock | I | −1 943 751 | 3 887 502 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | EVNIN LUKE | RDUS | Common Stock | I | −1 943 751 | 3 887 502 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | −713 849 | 1 427 698 | ||||||
| 2016-06-02 | 2016-05-24 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27 500 | 27 500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27 500 | 27 500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27 500 | 27 500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27 500 | 27 500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27 500 | 27 500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27 500 | 27 500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27 500 | 27 500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27 500 | 27 500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 29,89 | 62 500 | 62 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75 000 | 75 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 29,89 | 156 250 | 156 250 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75 000 | 75 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Purandare Dinesh | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75 000 | 75 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 29,89 | 62 500 | 62 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27 500 | 27 500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Fitzpatrick Lorraine A. | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75 000 | 75 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Snow David P. | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75 000 | 75 000 | |||||
| 2016-01-26 | 2016-01-25 | 4 | Fitzpatrick Lorraine A. | RDUS | Common Stock | D | 37,9700 | 100 | 4 | 200 | ||||
| 2016-01-26 | 2015-11-25 | 4 | Fitzpatrick Lorraine A. | RDUS | Common Stock | D | 60,5950 | 100 | 6 | 100 | ||||
| 2016-01-25 | 2016-01-22 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 31,6658 | 38 259 | 1 212 | 4 360 399 | ||||
| 2016-01-14 | 2016-01-13 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39,8977 | 50 000 | 1 995 | 4 322 140 | ||||
| 2015-12-07 | 2015-12-01 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 56,80 | 30 000 | 30 000 | |||||
| 2015-11-25 | 2015-11-23 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 7,80 | −25 000 | 743 785 | |||||
| 2015-11-25 | 2015-11-23 | 4 | Ward Robert | RDUS | Common Stock | D | 62,7650 | −25 000 | −1 569 | 0 | ||||
| 2015-11-25 | 2015-11-23 | 4 | Ward Robert | RDUS | Common Stock | D | 7,8000 | 25 000 | 195 | 25 000 | ||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2,74 | −1 | 0 | |||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2,74 | −5 682 | 0 | |||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Common Stock | D | 75,0000 | −5 683 | −426 | 0 | ||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Common Stock | D | 2,7400 | 5 683 | 16 | 0 | ||||
| 2015-11-05 | 2015-11-03 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2,74 | −13 333 | 0 | |||||
| 2015-11-05 | 2015-11-03 | 4 | Hattersley Gary | RDUS | Common Stock | D | 70,0000 | −13 333 | −933 | 0 | ||||
| 2015-11-05 | 2015-11-03 | 4 | Hattersley Gary | RDUS | Common Stock | D | 2,7400 | 13 333 | 37 | 0 | ||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2,05 | −10 428 | 0 | |||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 3,42 | −874 | 0 | |||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Common Stock | D | 65,0000 | −11 302 | −735 | 0 | ||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Common Stock | D | 2,0500 | 10 428 | 21 | 10 428 | ||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Common Stock | D | 3,4200 | 874 | 3 | 874 | ||||
| 2015-10-23 | 2015-10-21 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 3,42 | −1 501 | 874 | |||||
| 2015-10-23 | 2015-10-21 | 4 | Hattersley Gary | RDUS | Common Stock | D | 65,3600 | −1 501 | −98 | 0 | ||||
| 2015-10-23 | 2015-10-21 | 4 | Hattersley Gary | RDUS | Common Stock | D | 3,4200 | 1 501 | 5 | 1 501 | ||||
| 2015-09-28 | 2015-09-14 | 4 | Snow David P. | RDUS | Common Stock | D | 69,7900 | 6 000 | 419 | 6 000 | ||||
| 2015-09-11 | 2015-09-09 | 4 | Snow David P. | RDUS | Stock Option (Right to Buy) | D | 65,23 | 100 000 | 100 000 | |||||
| 2015-09-11 | 2015-09-09 | 4 | Snow David P. | RDUS | Performance Units | D | 25 000 | 25 000 | ||||||
| 2015-09-08 | 2015-08-31 | 4 | Purandare Dinesh | RDUS | Common Stock | D | 62,2000 | 200 | 12 | 200 | ||||
| 2015-08-24 | 2015-08-21 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 63,4454 | 50 000 | 3 172 | 4 272 140 | ||||
| 2015-08-24 | 2015-08-20 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 64,5552 | 50 000 | 3 228 | 4 222 140 | ||||
| 2015-08-19 | 2015-08-17 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 72,51 | 30 000 | 30 000 | |||||
| 2015-08-19 | 2015-08-17 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7,34 | −22 694 | 2 723 | |||||
| 2015-08-19 | 2015-08-17 | 4 | Graves Kurt | RDUS | Common Stock | D | 70,0000 | −22 694 | −1 589 | 0 | ||||
| 2015-08-19 | 2015-08-17 | 4 | Graves Kurt | RDUS | Common Stock | D | 7,3400 | 22 694 | 167 | 22 694 | ||||
| 2015-08-12 | 2015-08-10 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7,34 | −2 306 | 25 417 | |||||
| 2015-08-12 | 2015-08-10 | 4 | Graves Kurt | RDUS | Common Stock | D | 70,0000 | −2 306 | −161 | 0 | ||||
| 2015-08-12 | 2015-08-10 | 4 | Graves Kurt | RDUS | Common Stock | D | 7,3400 | 2 306 | 17 | 2 306 | ||||
| 2015-07-29 | 2015-07-27 | 4 | Fitzpatrick Lorraine A. | RDUS | Stock Option (Right to Buy) | D | 73,76 | 150 000 | 150 000 | |||||
| 2015-07-27 | 2015-07-23 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 74,0000 | 250 000 | 18 500 | 4 172 140 | ||||
| 2015-07-20 | 2015-07-16 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 77,64 | 30 000 | 30 000 | |||||
| 2015-07-08 | 2015-07-06 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7,34 | 25 000 | 27 723 | |||||
| 2015-07-08 | 2015-07-06 | 4 | Graves Kurt | RDUS | Common Stock | D | 69,4763 | −25 000 | −1 737 | 0 | ||||
| 2015-07-08 | 2015-07-06 | 4 | Graves Kurt | RDUS | Common Stock | D | 7,3400 | 25 000 | 184 | 25 000 | ||||
| 2015-06-22 | 2015-06-18 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7,34 | 25 000 | 52 723 | |||||
| 2015-06-22 | 2015-06-18 | 4 | Graves Kurt | RDUS | Common Stock | D | 55,0500 | −25 000 | −1 376 | 0 | ||||
| 2015-06-22 | 2015-06-18 | 4 | Graves Kurt | RDUS | Common Stock | D | 7,3400 | 25 000 | 184 | 25 000 | ||||
| 2015-06-05 | 2015-06-04 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 7,80 | −5 000 | 788 974 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Ward Robert | RDUS | Common Stock | D | 7,8000 | 5 000 | 39 | 5 000 | ||||
| 2015-05-26 | 2015-05-07 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15 000 | 15 000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15 000 | 15 000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Muenchbach Martin | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15 000 | 15 000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15 000 | 15 000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15 000 | 15 000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15 000 | 15 000 | |||||
| 2015-05-04 | 2015-05-01 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,4593 | 50 000 | 1 823 | 3 922 140 | ||||
| 2015-04-30 | 3/A | Hatzis-Schoch Brent | RDUS | Common Stock | D | 500 | ||||||||
| 2015-04-30 | 2015-04-29 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,2316 | 50 000 | 1 812 | 3 872 140 | ||||
| 2015-04-29 | 2015-04-27 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 38,3802 | 50 000 | 1 919 | 3 772 140 | ||||
| 2015-04-29 | 2015-04-28 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,5855 | 50 000 | 1 829 | 3 822 140 | ||||
| 2015-03-19 | 2015-03-18 | 4 | Purandare Dinesh | RDUS | Stock Option (Right to Buy) | D | 47,86 | 115 000 | 115 000 | |||||
| 2015-03-09 | 2015-03-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 47,0817 | 75 000 | 3 531 | 3 722 140 | ||||
| 2015-03-03 | 2015-03-02 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 44,18 | 60 000 | 60 000 | |||||
| 2015-02-27 | 2015-02-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 45,7386 | 35 000 | 1 601 | 3 647 140 | ||||
| 2015-02-26 | 3 | BB BIOTECH AG | RDUS | Common Stock | D | 7 224 280 | ||||||||
| 2015-02-26 | 3 | BB BIOTECH AG | RDUS | Common Stock | D | 7 224 280 | ||||||||
| 2015-02-26 | 3 | BB BIOTECH AG | RDUS | Common Stock | D | 7 224 280 | ||||||||
| 2015-01-20 | 2015-01-16 | 4/A | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 14,00 | −267 786 | 0 | |||||
| 2015-01-20 | 2015-01-16 | 4/A | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock Warrant | I | 14,00 | −121 396 | 0 | |||||
| 2015-01-20 | 2015-01-16 | 4/A | F2 Bioscience IV L.P. | RDUS | Common Stock Warrant | D | 14,00 | −249 932 | 0 | |||||
| 2015-01-20 | 2015-01-08 | 4/A | Jovan-Embiricos Morana By Fund | RDUS | Common Stock Warrant | I | 14,00 | −89 261 | 267 786 | |||||
| 2015-01-20 | 2015-01-08 | 4/A | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 14,00 | −89 261 | 267 786 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock Warrant | I | 2,69 | −121 396 | 0 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock Warrant | D | 2,69 | −249 932 | 0 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock | I | −871 851 | 0 | ||||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | D | −1 794 983 | 0 | ||||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 2,69 | −267 786 | 0 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock | D | −1 167 997 | 0 | ||||||
| 2015-01-15 | 2014-07-15 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock | I | −335 820 | 0 | ||||||
| 2015-01-15 | 2014-07-10 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock | I | −251 680 | 335 820 | ||||||
| 2015-01-15 | 2014-07-15 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | −335 820 | 0 | ||||||
| 2015-01-15 | 2014-07-10 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | −251 680 | 335 820 | ||||||
| 2015-01-12 | 2015-01-08 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 2,69 | −89 261 | 267 786 | |||||
| 2015-01-12 | 2015-01-08 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock | D | −389 331 | 1 167 997 | ||||||
| 2015-01-12 | 2015-01-08 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock Warrant | I | 2,69 | −89 261 | 267 786 | |||||
| 2015-01-12 | 2015-01-08 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | −389 331 | 1 167 997 | ||||||
| 2014-12-19 | 2014-12-17 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30 000 | 30 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 30,97 | 80 000 | 80 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 30,97 | 100 000 | 100 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Stoner Elizabeth | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30 000 | 30 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30 000 | 30 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Muenchbach Martin | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30 000 | 30 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 30,97 | 50 000 | 50 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30 000 | 30 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | HARRIS ALAN G | RDUS | Stock Option (Right to Buy) | D | 30,97 | −50 000 | 50 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 30,97 | 215 000 | 215 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Jovan-Embiricos Morana | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30 000 | 30 000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30 000 | 30 000 | |||||
| 2014-11-07 | 2014-11-01 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 18,41 | 30 000 | 30 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | HARRIS ALAN G | RDUS | Employee Stock Option (Right to Buy) | D | 8,78 | 50 000 | 50 000 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Muenchbach Martin By Fund | RDUS | Series B-2 Convertible Preferred Stock | I | −12 211 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Muenchbach Martin By Fund | RDUS | Common Stock | I | 96 160 | 1 393 443 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Series B-2 Convertible Preferred Stock | I | −110 713 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Series B-2 Convertible Preferred Stock | I | −227 938 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 8,0000 | 587 500 | 4 700 | 587 500 | ||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 871 851 | 871 851 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 1 794 983 | 1 794 983 | ||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1 175 000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1 175 000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1 175 000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1 175 000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1 175 000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1 175 000 | ||||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Series B-2 Convertible Preferred Stock | I | −110 713 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Series B-2 Convertible Preferred Stock | D | −227 938 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | I | 8,0000 | 587 500 | 4 700 | 587 500 | ||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | I | 871 851 | 871 851 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | D | 1 794 983 | 1 794 983 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Series B-2 Convertible Preferred Stock | D | −65 125 | 0 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Series B Convertible Preferred Stock | D | −97 688 | 0 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Series A-1 Convertible Preferred Stock | D | −122 820 | 0 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 8,0000 | 1 000 000 | 8 000 | 2 705 040 | ||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 187 262 | 1 705 040 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 500 029 | 1 517 778 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 428 459 | 1 017 749 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 589 290 | 589 290 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | −105 162 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | −84 536 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Series B Convertible Preferred Stock | I | −32 563 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Common Stock | I | 1 297 283 | 1 297 283 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | −184 242 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | −114 537 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | −71 638 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | −859 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | −3 511 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | −4 346 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | −1 468 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | −1 340 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | −5 477 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | −6 779 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | −2 291 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | −3 752 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | −15 327 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | −18 975 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | −6 414 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | −44 395 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | −181 364 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | −224 528 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | −75 899 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | −2 985 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | −12 194 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | −15 096 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | −5 103 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 2 141 547 | 2 141 547 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 59 445 | 59 445 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 92 734 | 92 734 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 259 567 | 259 567 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 3 071 454 | 3 071 454 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 206 506 | 206 506 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series B Convertible Preferred Stock | I | −162 813 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series A-3 Convertible Preferred Stock | I | −53 331 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series A-2 Convertible Preferred Stock | I | −402 115 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series A-1 Convertible Preferred Stock | I | −384 261 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 1 088 251 | 5 831 253 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 714 095 | 4 743 002 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 255 881 | 4 028 907 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 1 929 344 | 3 773 026 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 1 843 682 | 1 843 682 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series B Convertible Preferred | I | −91 175 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series A-3 Convertible Preferred Stock | I | −53 331 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series A-2 Convertible Preferred Stock | I | −217 873 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series A-1 Convertible Preferred Stock | I | −269 724 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 694 449 | 3 689 706 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 399 891 | 2 995 257 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 255 881 | 2 595 366 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 1 045 351 | 2 339 485 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 1 294 134 | 1 294 134 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series B Convertible Preferred | I | −91 175 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series A-3 Convertible Preferred Stock | I | −53 331 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series A-2 Convertible Preferred Stock | I | −217 873 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series A-1 Convertible Preferred Stock | I | −269 724 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 694 449 | 3 689 706 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 399 891 | 2 995 257 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 255 881 | 2 595 366 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 1 045 351 | 2 339 485 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 1 294 134 | 1 294 134 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Series B Convertible Preferred Stock | I | −71 638 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Series A-2 Convertible Preferred Stock | I | −184 242 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Series A-1 Convertible Preferred Stock | I | −114 537 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 393 802 | 2 141 547 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 314 204 | 1 747 745 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 883 993 | 1 433 541 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 549 548 | 549 548 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Series B Convertible Preferred Stock | I | −325 627 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 1 557 328 | 1 557 328 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | F2 Bioscience III, L.P. | RDUS | Series B Convertible Preferred Stock | D | −325 627 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock | D | 1 557 328 | 1 557 328 | ||||||
| 2014-06-09 | 2014-06-05 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 8,00 | 65 789 | 65 789 | |||||
| 2014-06-09 | 2014-06-05 | 4 | HARRIS ALAN G | RDUS | Stock Option (Right to Buy) | D | 8,00 | 131 578 | 131 578 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Durand Mark | RDUS | Stock Option (Right to Buy) | D | 8,00 | 175 438 | 175 438 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Bain Capital Public Equity Management, LLC | NONE | Common Stock | I | 8,0000 | 500 000 | 4 000 | 1 943 241 | ||||
| 2014-06-09 | 2014-06-05 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 8,00 | 120 614 | 120 614 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 8,00 | 32 894 | 32 894 | |||||
| 2014-04-01 | 2014-03-28 | 4 | Bain Capital Public Equity Management, LLC | NONE | Common Stock Warrants | I | 6,14 | 6,1420 | 67 160 | 412 | 67 160 | |||
| 2014-04-01 | 2014-03-28 | 4 | Bain Capital Public Equity Management, LLC | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 26 684 | 1 639 | 26 684 | ||||
| 2014-04-01 | 2013-04-23 | 4 | Bain Capital Public Equity Management, LLC | NONE | Common Stock Warrants | I | 6,14 | 6,1420 | 203 518 | 1 250 | 203 518 | |||
| 2014-04-01 | 2013-04-23 | 4 | Bain Capital Public Equity Management, LLC | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 81 407 | 5 000 | 81 407 | ||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Common Stock Warrant | I | 6,14 | 276 783 | 276 783 | |||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Common Stock Warrant | I | 6,14 | 569 845 | 569 845 | |||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 110 713 | 6 800 | 110 713 | ||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 227 938 | 14 000 | 227 938 | ||||
| 2014-02-21 | 2014-02-19 | 4 | BIOTECH GROWTH N V | NONE | Common Stock Warrant | D | 6,14 | 162 813 | 162 813 | |||||
| 2014-02-21 | 2014-02-19 | 4 | BIOTECH GROWTH N V | NONE | Series B-2 Convertible Preferred Stock | D | 61,4200 | 65 125 | 4 000 | 65 125 | ||||
| 2014-02-19 | 2014-02-14 | 4 | Muenchbach Martin By Fund | NONE | Common Stock Warrant | I | 6,14 | 30 528 | 111 936 | |||||
| 2014-02-19 | 2014-02-14 | 4 | Muenchbach Martin By Fund | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 12 211 | 750 | 12 211 | ||||
| 2014-02-19 | 2014-02-16 | 4 | Yates John | NONE | Stock Option (Right to Buy) | D | 3,42 | 3,4200 | 300 000 | 1 026 | 300 000 | |||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Common Stock Warrant | I | 6,14 | 276 783 | 276 783 | |||||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Common Stock Warrant | I | 6,14 | 569 845 | 569 845 | |||||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 110 713 | 6 800 | 110 713 | ||||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 227 938 | 14 000 | 227 938 | ||||
| 2014-02-19 | 2014-02-16 | 4 | Ward Robert | NONE | Stock Option (Right to Buy) | D | 3,42 | 3,4200 | 97 199 | 332 | 97 199 | |||
| 2014-02-19 | 2014-02-16 | 4 | Ward Robert | NONE | Stock Option (Right to Buy) | D | 3,42 | 3,4200 | 1 810 262 | 6 191 | 1 810 262 | |||
| 2014-02-19 | 2014-02-16 | 4 | Williams Gregory C. | NONE | Stock Option (Right to Buy) | D | 3,42 | 3,4200 | 400 000 | 1 368 | 400 000 | |||
| 2014-01-06 | 2013-12-31 | 4 | Nordic Bioscience Clinical Development VII A/S | NONE | Series A-6 Convertible Preferred Stock | D | 496 111 | 5 025 540 | ||||||
| 2013-12-06 | 3 | Lyttle Cecil Richard | NONE | Common Stock | D | 66 666 | ||||||||
| 2013-11-18 | 2013-11-14 | 4 | Fromkin Andrew J. | NONE | Stock Option (Right to Buy) | D | 3,45 | 3,4500 | 2 427 133 | 8 374 | 2 427 133 | |||
| 2013-04-30 | 2013-04-23 | 4 | EVNIN LUKE | RDUS | Common Stock Warrant | I | 6,14 | 6,1420 | 407 034 | 2 500 | 0 | |||
| 2013-04-30 | 2013-04-23 | 4 | EVNIN LUKE | RDUS | Series B Convertible Preferred Stock | I | 61,4200 | 162 813 | 10 000 | 0 | ||||
| 2013-04-30 | 2013-04-23 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock Warrant | I | 6,14 | 6,1420 | 227 939 | 1 400 | 227 939 | |||
| 2013-04-30 | 2013-04-23 | 4 | MPM BIOVENTURES III LLC | RDUS | Series B Convertible Preferred Stock | I | 61,4200 | 91 175 | 5 600 | 91 175 | ||||
| 2013-04-30 | 2013-04-23 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock Warrant | I | 6,14 | 6,1420 | 227 939 | 1 400 | 0 | |||
| 2013-04-30 | 2013-04-23 | 4 | GALAKATOS NICHOLAS | RDUS | Series B Convertible Preferred Stock | I | 61,4200 | 91 175 | 5 600 | 0 | ||||
| 2013-04-30 | 2013-04-23 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock Warrant | I | 6,14 | 6,1420 | 179 095 | 1 100 | 179 095 | |||
| 2013-04-30 | 2013-04-23 | 4 | MPM BioVentures IV LLC | RDUS | Series B Convertible Preferred Stock | I | 61,4200 | 71 638 | 4 400 | 71 638 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 179 095 | 179 095 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 71 638 | 4 400 | 71 638 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 3 670 | 3 670 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 1 468 | 90 | 1 468 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 5 728 | 5 728 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 2 291 | 141 | 2 291 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 16 035 | 16 035 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 6 414 | 394 | 6 414 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 189 748 | 189 748 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 75 899 | 4 662 | 75 899 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 12 758 | 12 758 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 5 103 | 313 | 5 103 | ||||
| 2013-04-25 | 2013-04-23 | 4 | Muenchbach Martin By Fund | NONE | Common Stock Warrant | I | 6,14 | 81 408 | 81 408 | |||||
| 2013-04-25 | 2013-04-23 | 4 | Muenchbach Martin By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 32 563 | 2 000 | 32 563 | ||||
| 2013-04-25 | 2013-04-23 | 4 | BIOTECH GROWTH N V | NONE | Common Stock Warrant | D | 6,14 | 244 220 | 244 220 | |||||
| 2013-04-25 | 2013-04-23 | 4 | BIOTECH GROWTH N V | NONE | Series B Convertible Preferred Stock | D | 61,4200 | 97 688 | 6 000 | 97 688 | ||||
| 2012-09-28 | 2011-12-15 | 4 | BRENNER LOUIS MD | NONE | Stock Option (Right to Buy) | D | 3,89 | 3,8900 | 62 700 | 244 | 451 700 | |||
| 2012-09-28 | 2011-12-15 | 4 | BRENNER LOUIS MD | NONE | Stock Option (Right to Buy) | D | 3,89 | 3,8900 | 37 600 | 146 | 389 000 | |||
| 2012-09-28 | 2011-12-15 | 4 | BRENNER LOUIS MD | NONE | Stock Option (Right to Buy) | D | 3,89 | 3,8900 | 351 400 | 1 367 | 351 400 | |||
| 2012-06-22 | 2011-12-15 | 4 | WYZGA MICHAEL S | NONE | Stock Option (Right to Buy) | D | 3,89 | 3,8900 | −1 530 000 | −5 952 | 1 530 000 | |||
| 2012-06-19 | 2012-04-11 | 4 | Franken Michael | NONE | Stock Option (Right to Buy) | D | 4,21 | 4,2100 | 70 000 | 295 | 70 000 | |||
| 2012-02-02 | 2011-12-14 | 5 | Bain Capital Public Equity Management, LLC | NONE | Series A-1 Convertible Preferred Stock | I | 81,4200 | 40 940 | 3 333 | 122 820 | ||||
| 2012-02-02 | 2011-11-18 | 5 | Bain Capital Public Equity Management, LLC | NONE | Series A-1 Convertible Preferred Stock | I | 81,4200 | 40 940 | 3 333 | 81 880 | ||||
| 2011-05-24 | 3 | CAVANAUGH JAMES H | NONE | Common Stock | D | 83 113 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
